- ICH GCP
- Реестр клинических исследований США
- Клиническое испытание NCT07733271
Robot-Assisted Closed Reduction and Internal Fixation for Extra-Articular Distal Tibial Fractures
Key Technology Research and Development for Intelligent Minimally Invasive Precision Treatment of Fractures (Sub-project 4: A Randomized Controlled Trial of Robot-Assisted Closed Reduction and Internal Fixation for Distal Tibial Fractures)
Обзор исследования
Статус
Вмешательство/лечение
Тип исследования
Регистрация (Оцененный)
Фаза
- Непригодный
Контакты и местонахождение
Контакты исследования
- Имя: Chunpeng Zhao, MD / Chief Physician
- Номер телефона: +86 18610012704
- Электронная почта: zcpllza2008@163.com
Места учебы
-
-
Beijing Municipality
-
Beijing, Beijing Municipality, Китай, 100035
- Рекрутинг
- Beijing Jishuitan Hospital
-
Контакт:
- Chunpeng Zhao, MD / Chief Physician
- Номер телефона: +86 18610012704
- Электронная почта: zcpllza2008@163.com
-
Beijing, Beijing Municipality, Китай, 100035
- Рекрутинг
- Aerospace Center Hospital
-
Контакт:
- Yonghui Liang, MD / Chief Physician
-
-
Критерии участия
Критерии приемлемости
Возраст, подходящий для обучения
- Взрослый
- Пожилой взрослый
Принимает здоровых добровольцев
Описание
Inclusion Criteria:
- Unilateral, acute, closed distal tibial fractures (Arbeitsgemeinschaft für Osteosynthesefragen/Orthopaedic Trauma Association AO/OTA 43-A)
- Time from injury to surgery < 21 days
- Able to walk independently before injury (assistive devices allowed)
Exclusion Criteria:
- Open fractures or multiple severe traumas requiring priority treatment
- Asymmetrical lower extremities, or prior malunion of the ipsilateral tibia, or pre-existing deformities significantly affecting rotation/length evaluation
- Ipsilateral fractures combined with other sites
- Pathological fractures (tumor/metabolic)
- Prior complex implants in place or previous surgeries significantly affecting evaluation
- Active infection or severe systemic medical contraindications (unable to tolerate anesthesia/surgery)
- Cognitive impairment, poor compliance, pregnancy, or lactation
- Poor local skin conditions (e.g., obvious blisters, severe soft tissue injury)
- Deemed unsuitable by the investigator (e.g., unable to follow up as planned) or refused randomization/enrollment
Учебный план
Как устроено исследование?
Детали дизайна
- Основная цель: Уход
- Распределение: Рандомизированный
- Интервенционная модель: Параллельное назначение
- Маскировка: Одинокий
Оружие и интервенции
Группа участников / Армия |
Вмешательство/лечение |
|---|---|
|
Экспериментальный: Robot-Assisted Group
|
The patient undergoes automated or human-robot collaborative closed fracture reduction powered by an intelligent robotic system.
The system integrates deep-learning-based bone segmentation, automatic reduction planning, and a self-adaptive 2D-3D image registration framework to achieve sub-millimeter positioning feedback and force-position collaborative security gates.
Following successful reduction, the fracture is fixed with a distal tibial locking plate via the minimally invasive percutaneous plate osteosynthesis (MIPO) technique.
|
|
Активный компаратор: Traditional Group
|
The patient undergoes conventional closed or open fracture reduction performed entirely by the surgical team based on traditional clinical experience under ordinary C-arm fluoroscopic guidance.
Internal fixation is achieved using standard distal tibial locking plates or intramedullary nails according to the surgeon's choice and standard of care.
|
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Rate of Excellent or Good Closed Fracture Reduction Assessed by Postoperative Low-Dose CT-Based 3D Quantitative Reduction Grading Criteria
Временное ограничение: From completion of surgery to postoperative low-dose CT assessment, assessed up to 2 weeks after surgery
|
The percentage of patients achieving "Excellent" or "Good" anatomical closed reduction. Reduction quality is measured on post-op CT via RadiAnt DICOM Viewer and 3D Slicer based on the worst-performing of 3 dimensions:
The final reduction grade is determined by the lowest category among these parameters, and the primary outcome represents the proportion of patients graded as Excellent or Good. |
From completion of surgery to postoperative low-dose CT assessment, assessed up to 2 weeks after surgery
|
Вторичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Total Operation Time Measured in Minutes
Временное ограничение: From initial skin incision to completion of skin closure, assessed up to 8 hours
|
Total operation time will be measured in minutes and defined as the duration from initial skin incision to completion of skin closure.
|
From initial skin incision to completion of skin closure, assessed up to 8 hours
|
|
Number of Intraoperative C-Arm Fluoroscopy Shots
Временное ограничение: From initial skin incision to completion of skin closure, assessed up to 8 hours
|
The number of intraoperative fluoroscopy shots taken using the C-arm during the surgical procedure will be recorded.
|
From initial skin incision to completion of skin closure, assessed up to 8 hours
|
|
Intraoperative Blood Loss Measured in Milliliters
Временное ограничение: From initial skin incision to completion of skin closure, assessed up to 8 hours
|
The estimated total volume of blood loss during the surgical procedure will be recorded in milliliters.
|
From initial skin incision to completion of skin closure, assessed up to 8 hours
|
|
Length of Hospital Stay Measured in Days
Временное ограничение: From hospital admission to hospital discharge, assessed up to 30 days
|
The length of hospital stay will be recorded in days from admission to hospital discharge.
|
From hospital admission to hospital discharge, assessed up to 30 days
|
|
Robot-Assisted Reduction Planning and Execution Time Measured in Minutes in the Experimental Group
Временное ограничение: From initial skin incision to completion of the reduction maneuver, assessed up to 8 hours
|
For participants assigned to the experimental group, the robot-assisted reduction planning and execution time will be recorded in minutes.
This time is defined as the duration from completion of robotic arm setup to completion of the reduction maneuver.
|
From initial skin incision to completion of the reduction maneuver, assessed up to 8 hours
|
|
Time to Radiographic Fracture Union Assessed by Standard X-Ray
Временное ограничение: From completion of surgery to the first documented radiographic evidence of fracture union, assessed up to 12 months after surgery
|
Time to radiographic fracture union will be measured in weeks using standard anteroposterior and lateral X-rays.
Fracture union is defined as cortical bridging in at least 3 of 4 cortices with no significant pain during weight-bearing.
Low-dose CT may be used to confirm fracture union in uncertain cases.
|
From completion of surgery to the first documented radiographic evidence of fracture union, assessed up to 12 months after surgery
|
|
Radiographic Fracture Union Rate Assessed by Standard X-Ray
Временное ограничение: From completion of surgery to the first documented radiographic evidence of fracture union, assessed up to 12 months after surgery
|
The percentage of participants achieving radiographic fracture union will be assessed using standard anteroposterior and lateral X-rays.
Low-dose CT may be used to confirm fracture union in uncertain cases.
|
From completion of surgery to the first documented radiographic evidence of fracture union, assessed up to 12 months after surgery
|
|
Foot and Ankle Ability Measure-Activities of Daily Living Score
Временное ограничение: From baseline to 1 month, 3 months, 6 months and 12 months after surgery
|
The Foot and Ankle Ability Measure-Activities of Daily Living (FAAM-ADL) score is used to assess the functional status of patients with foot and ankle disorders.
The subscale consists of 21 items, with a maximum total raw score of 84.
The scores are converted into a percentage score ranging from 0% to 100%, where a higher score indicates a higher level of functional ability.
|
From baseline to 1 month, 3 months, 6 months and 12 months after surgery
|
|
Lower Extremity Functional Scale Score
Временное ограничение: From baseline to 1 month, 3 months, 6 months and 12 months after surgery
|
The Lower Extremity Functional Scale (LEFS) is used to evaluate the patient's lower extremity function and ability to perform everyday tasks.
The scale contains 20 items with a total raw score ranging from 0 to 80, where a higher score represents better functional status.
|
From baseline to 1 month, 3 months, 6 months and 12 months after surgery
|
|
EuroQol 5-Dimension 5-Level Health Index
Временное ограничение: From baseline to 1 month, 3 months, 6 months and 12 months after surgery
|
The EuroQol 5-Dimension 5-Level (EQ-5D-5L) questionnaire evaluates health-related quality of life across 5 dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.
The raw response is converted into a health state index score typically ranging from 0 (representing death) to 1 (representing perfect health), with higher scores reflecting better overall quality of life.
|
From baseline to 1 month, 3 months, 6 months and 12 months after surgery
|
|
EuroQol Visual Analogue Scale Score
Временное ограничение: From baseline to 1 month, 3 months, 6 months and 12 months after surgery
|
The EuroQol Visual Analogue Scale (EQ VAS) provides a quantitative measure of the patient's self-rated overall health status.
The score is recorded on a visual scale ranging from 0 to 100, where 0 represents the worst imaginable health state and 100 represents the best imaginable health state.
|
From baseline to 1 month, 3 months, 6 months and 12 months after surgery
|
|
Incidence of Intraoperative Complications
Временное ограничение: From initial skin incision to completion of skin closure, assessed up to 8 hours
|
The percentage of participants experiencing intraoperative complications, including neurovascular injury, cortical perforation, abnormal bleeding, device failure, registration failure requiring manual takeover or change of reduction strategy, will be recorded.
|
From initial skin incision to completion of skin closure, assessed up to 8 hours
|
|
Incidence of Postoperative Complications
Временное ограничение: From completion of surgery to postoperative complication assessment, assessed up to 12 months after surgery
|
The percentage of participants experiencing postoperative complications, including wound problems or infection, thrombotic events, internal fixation failure, or loss of reduction, will be recorded.
|
From completion of surgery to postoperative complication assessment, assessed up to 12 months after surgery
|
|
Incidence of Reoperation
Временное ограничение: From completion of surgery to reoperation assessment, assessed up to 12 months after surgery
|
The percentage of participants requiring reoperation after the index surgery will be recorded.
|
From completion of surgery to reoperation assessment, assessed up to 12 months after surgery
|
Соавторы и исследователи
Спонсор
Соавторы
Даты записи исследования
Изучение основных дат
Начало исследования (Действительный)
Первичное завершение (Оцененный)
Завершение исследования (Оцененный)
Даты регистрации исследования
Первый отправленный
Впервые представлено, что соответствует критериям контроля качества
Первый опубликованный (Действительный)
Обновления учебных записей
Последнее опубликованное обновление (Действительный)
Последнее отправленное обновление, отвечающее критериям контроля качества
Последняя проверка
Дополнительная информация
Термины, связанные с этим исследованием
Дополнительные соответствующие термины MeSH
Другие идентификационные номера исследования
- Ji-Lun [K2026] No. [190]-00
Планирование данных отдельных участников (IPD)
Планируете делиться данными об отдельных участниках (IPD)?
Информация о лекарствах и устройствах, исследовательские документы
Изучает лекарственный продукт, регулируемый FDA США.
Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .